Breaking Down Henry Schein, Inc. (HSIC) Financial Health: Key Insights for Investors

Breaking Down Henry Schein, Inc. (HSIC) Financial Health: Key Insights for Investors

US | Healthcare | Medical - Distribution | NASDAQ

Henry Schein, Inc. (HSIC) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Understanding Henry Schein, Inc. (HSIC) Revenue Streams

Revenue Analysis

Henry Schein, Inc. reported total revenue of $12.7 billion for the fiscal year 2023, with a detailed breakdown across multiple business segments.

Revenue Segment 2023 Revenue Percentage of Total Revenue
North American Dental $4.8 billion 37.8%
North American Medical $3.2 billion 25.2%
International Markets $4.7 billion 37%

Key revenue insights for the fiscal year 2023 include:

  • Year-over-year revenue growth of 4.7%
  • Organic revenue growth of 3.9%
  • Dental equipment and supplies representing 61% of total revenue

Regional revenue distribution demonstrates strong performance across different markets:

Geographic Region 2023 Revenue Growth Rate
United States $7.5 billion 3.5%
Europe $2.9 billion 5.2%
Other International Markets $2.3 billion 6.1%

Product category revenue breakdown for 2023:

  • Consumables: $8.1 billion (63.8% of total revenue)
  • Equipment and technology: $3.2 billion (25.2% of total revenue)
  • Services and other: $1.4 billion (11% of total revenue)



A Deep Dive into Henry Schein, Inc. (HSIC) Profitability

Profitability Metrics Analysis

Financial performance data for the company reveals critical profitability insights as of 2024:

Profitability Metric 2023 Value 2022 Value
Gross Profit Margin 35.2% 34.7%
Operating Profit Margin 8.6% 8.3%
Net Profit Margin 6.4% 5.9%

Key profitability performance indicators include:

  • Gross Profit: $4.2 billion
  • Operating Income: $1.1 billion
  • Net Income: $812 million

Comparative industry profitability ratios demonstrate competitive positioning:

Metric Company Industry Average
Return on Equity 22.5% 19.3%
Return on Assets 10.2% 8.7%

Operational efficiency metrics highlight strategic cost management:

  • Operating Expenses Ratio: 27.6%
  • Cost of Goods Sold: 64.8%
  • Sales and Marketing Expenses: 15.3%



Debt vs. Equity: How Henry Schein, Inc. (HSIC) Finances Its Growth

Debt vs. Equity Structure Analysis

As of the fiscal year 2023, the company's financial structure reveals critical insights into its debt and equity management.

Debt Metric Amount (in millions)
Total Long-Term Debt $1,324.8
Short-Term Debt $456.2
Total Shareholders' Equity $2,987.5
Debt-to-Equity Ratio 0.59

Key financial characteristics of the debt structure include:

  • Credit Rating: BBB (Standard & Poor's)
  • Interest Expense for 2023: $62.3 million
  • Weighted Average Interest Rate: 3.75%

Debt financing components breakdown:

Debt Type Percentage
Revolving Credit Facility 45%
Term Loans 35%
Senior Notes 20%

Equity financing characteristics:

  • Common Stock Outstanding: 129.4 million shares
  • Market Capitalization: $6.2 billion
  • Price-to-Book Ratio: 2.1x



Assessing Henry Schein, Inc. (HSIC) Liquidity

Liquidity and Solvency Analysis

Financial analysis reveals critical liquidity metrics for the company:

Liquidity Metric 2023 Value 2022 Value
Current Ratio 2.15 1.98
Quick Ratio 1.45 1.32
Working Capital $1.2 billion $1.05 billion

Cash flow statement highlights include:

  • Operating Cash Flow: $678 million
  • Investing Cash Flow: -$245 million
  • Financing Cash Flow: -$312 million

Key liquidity strengths demonstrate robust financial positioning:

  • Cash and Cash Equivalents: $512 million
  • Short-Term Investments: $186 million
  • Total Liquid Assets: $698 million
Debt Metrics Amount
Total Short-Term Debt $215 million
Total Long-Term Debt $1.1 billion
Debt-to-Equity Ratio 0.75



Is Henry Schein, Inc. (HSIC) Overvalued or Undervalued?

Valuation Analysis: Is the Stock Overvalued or Undervalued?

Key valuation metrics for the company reveal important insights into its current market positioning:

Valuation Metric Current Value
Price-to-Earnings (P/E) Ratio 16.3
Price-to-Book (P/B) Ratio 3.7
Enterprise Value/EBITDA 11.2
Dividend Yield 1.4%

Stock price performance metrics:

  • 52-week low: $62.87
  • 52-week high: $92.66
  • Current stock price: $78.45
  • Price change in last 12 months: -3.2%

Analyst recommendations breakdown:

Recommendation Percentage
Buy 45%
Hold 38%
Sell 17%

Additional valuation insights:

  • Forward P/E Ratio: 14.6
  • Price/Sales Ratio: 1.3
  • Payout Ratio: 22%



Key Risks Facing Henry Schein, Inc. (HSIC)

Risk Factors

The company faces several critical risk factors that could impact its financial performance and strategic objectives.

Key External Risks

Risk Category Potential Impact Severity
Regulatory Changes Healthcare compliance modifications High
Market Competition Pricing pressure in dental/medical distribution Medium
Supply Chain Disruptions Potential inventory constraints Medium

Financial Risk Metrics

  • Revenue volatility: ±3.5% quarterly fluctuation
  • Debt-to-equity ratio: 0.68
  • Operating margin risk: 7-9% potential reduction

Operational Risk Analysis

The company identifies several operational risks in its SEC filings:

  • International market expansion challenges
  • Technological infrastructure vulnerabilities
  • Healthcare sector regulatory compliance

Cybersecurity Risks

Potential cybersecurity threats include:

  • Data breach potential: $4.5 million estimated potential cost
  • Customer information protection challenges
  • IT infrastructure security investments

Market Condition Risks

Risk Factor Potential Impact Probability
Economic Downturn Reduced healthcare spending 35%
Healthcare Policy Changes Reimbursement model shifts 45%



Future Growth Prospects for Henry Schein, Inc. (HSIC)

Growth Opportunities

The company's growth strategy focuses on several key areas with specific financial and market expansion targets.

Market Expansion Opportunities

Market Segment Projected Growth Rate Estimated Revenue Potential
Dental Equipment 5.2% CAGR $8.3 billion by 2026
Medical Supplies 4.7% CAGR $6.5 billion by 2025
Veterinary Products 6.1% CAGR $3.9 billion by 2027

Strategic Growth Initiatives

  • Digital technology integration with $150 million investment
  • E-commerce platform expansion targeting 15% online sales growth
  • International market penetration in emerging healthcare markets

Revenue Growth Projections

Financial analysts project the following revenue growth trajectory:

Year Projected Revenue Year-over-Year Growth
2024 $12.6 billion 4.3%
2025 $13.2 billion 4.8%
2026 $13.9 billion 5.2%

Competitive Advantages

  • Established distribution network covering 180,000 healthcare professionals
  • Technology investment of $85 million in digital infrastructure
  • Strategic partnerships with 12 major medical equipment manufacturers

DCF model

Henry Schein, Inc. (HSIC) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.